Rockwell Medical RMTI
NASDAQ RMTI
$7.53 +0.03 (+0.40%)
At close: Aug 20, 2026 · 1:00 PM UTC

Rockwell Medical (RMTI) Income towards Parent Company (2010 - 2026)

Rockwell Medical's (RMTI) quarterly Income towards Parent Company came in at -$7.2 million in Q1 2026, down 290.63% YoY from $3.8 million in Q1 2025, and down 336.77% on a QoQ basis from -$1.7 million in Q4 2025.

Rockwell Medical (RMTI) Income towards Parent Company (2010 - 2026) Analysis & Trends

Rockwell Medical (RMTI) has 17 years of Income towards Parent Company data on file, last reported at -$7.2 million in Q1 2026.

  • Quarterly Income towards Parent Company fell 290.63% year-over-year to -$7.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13.5 million (down 2145.27% YoY) and the FY2025 annual result came in at -$11.4 million, up 86.57% from the prior year.
  • Income towards Parent Company fell to -$7.2 million in Q1 2026, from -$1.7 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $1.5 million in Q3 2024 to a low of -$7.2 million in Q1 2026.
  • A 5-year average of -$2.5 million and a median of -$1.9 million in 2022 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2024 — Income towards Parent Company jumped 170.82% — and 2025, when it plunged 2748.98%.
  • Tracing RMTI's Income towards Parent Company over 5 years: stood at -$1.9 million in 2022, then gained by 14.93% to -$1.6 million in 2023, then soared by 76.94% to -$372000.0 in 2024, then plunged by 343.82% to -$1.7 million in 2025, then tumbled by 336.77% to -$7.2 million in 2026.
  • The last three Income towards Parent Company figures came in at -$7.2 million (Q1 2026), -$1.7 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.96 Bn 43.00 Bn -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn -
10 Rockwell Medical 29.77 Mn 4.98 Mn 3.24 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.32 Mn
Mar 31, 2026 -7.21 Mn
Dec 31, 2025 -1.65 Mn
Sep 30, 2025 -2.08 Mn
Jun 30, 2025 -2.60 Mn
Mar 31, 2025 -1.85 Mn
Dec 31, 2024 -372,000.00
Sep 30, 2024 1.52 Mn
Jun 30, 2024 98,000.00
Mar 31, 2024 -1.74 Mn
Dec 31, 2023 -1.61 Mn
Sep 30, 2023 -2.14 Mn
Jun 30, 2023 -3.39 Mn
Mar 31, 2023 -1.79 Mn
Dec 31, 2022 -1.90 Mn
Sep 30, 2022 -4.19 Mn
Jun 30, 2022 -4.97 Mn
Mar 31, 2022 -7.17 Mn
Dec 31, 2021 -8.41 Mn
Sep 30, 2021 -7.58 Mn